NCT07790458 Automated Non-Invasive Blood Pressure Study
| NCT ID | NCT07790458 |
| Status | Recruiting |
| Phase | — |
| Sponsor | GE Healthcare |
| Condition | Blood Pressure |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-04-14 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2025-04-14 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to design and implement methods to make an algorithm to estimate blood pressure changes.
Eligibility Criteria
Inclusion Criteria: 1. Able to provide written informed consent or have a LDR to provide written informed consent; 2. Are being cared for in OR, PACU or ICU and are expected to remain in the unit for the duration of the study procedure; 3. Have an invasive blood pressure measurement as a standard of care; AND 4. Are 18 years of age or older. Exclusion Criteria: 1. Are known to be pregnant; 2. Are breastfeeding; 3. Are suffering from infection(s) that require isolation; OR 4. Have an external heart assistant device. 5. PI or caring physician decision due to subject health condition
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07790458 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Blood Pressure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07790458 currently recruiting?
Yes, NCT07790458 is actively recruiting participants. Contact the research team at erika.wilkman@hus.fi for enrollment information.
Where is the NCT07790458 trial being conducted?
This trial is being conducted at Helsinki, Finland, Helsinki, Finland.
Who is sponsoring the NCT07790458 clinical trial?
NCT07790458 is sponsored by GE Healthcare. The trial plans to enroll 50 participants.